Diagnosing China's impact on patients, policy and the future of global health.
The go-to newsletter & podcast for policymakers, investors, biopharma & medtech industry, and public health leaders.
Covering the priorities of both the leadership and the general public in China and views you do not normally see from mainstream English-language media
Now the decline of this niche has driven out everybody else I can be on it. I am doing this also because my generalist editor will filter technicalities out.